Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Ethereum price struggles near $2,100 amid macro pressures but shows signs of long-term potential.

Market News
19 May 2026
CryptoTicker
View Source
Bearish
pluang ai news

Ethereum's price has dropped about 50% over five years, currently hovering around $2,116 amid macroeconomic pressures like rising oil prices and geopolitical tensions. Short-term risks include potential declines to $2,000 or lower, but strong on-chain fundamentals such as increased staking and institutional tokenization suggest a possible long-term recovery. Investors should consider their risk tolerance and time horizon, with dollar-cost averaging recommended around key support levels.

More News

New free platform reveals how AI search engines show your brand online

New free platform reveals how AI search engines show your brand online

TheBestReputation launched AIOverview.com, a free tool that scans five major AI search engines—ChatGPT, Claude, Google AI Overview, Gemini, and Perplexity—to show businesses how their brand appears in AI-generated search results. This is crucial as o...

Others
Neutral
16 minutes ago
Vuzix showcases advanced waveguide smart glasses for defense at SOF Week 2026 in Florida

Vuzix showcases advanced waveguide smart glasses for defense at SOF Week 2026 in Florida

Vuzix Corporation is exhibiting its advanced AI-powered smart glasses and waveguide solutions at SOF Week 2026 in Tampa, Florida. These products are designed for defense use, offering mission-ready optical performance in challenging environments, inc...

Market News
Neutral
31 minutes ago
MoneyFlare launches AI trading bot for automated crypto and stock market trading.

MoneyFlare launches AI trading bot for automated crypto and stock market trading.

MoneyFlare has introduced an AI-powered trading bot designed to automate trading in both cryptocurrency and stock markets. This tool aims to simplify automated trading by handling market monitoring, data analysis, strategy execution, and trade manage...

Others
Bullish
1 hour ago
Over 50 companies advance 55+ new pulmonary arterial hypertension drugs in clinical trials.

Over 50 companies advance 55+ new pulmonary arterial hypertension drugs in clinical trials.

More than 50 companies are actively developing over 55 new drugs for pulmonary arterial hypertension (PAH), a serious lung-related heart condition. These drugs are in various clinical trial stages, with several in late-stage development, aiming to im...

Market News
Bullish
1 hour ago
ANKTIVA combo shows higher response rates and fewer side effects vs rival bladder cancer therapies

ANKTIVA combo shows higher response rates and fewer side effects vs rival bladder cancer therapies

ImmunityBio presented data showing its ANKTIVA plus BCG treatment outperformed two FDA-approved bladder cancer therapies, Adstiladrin and INLEXZO. The ANKTIVA combo achieved a 69.7% complete response rate versus 53.4% for Adstiladrin, with a longer m...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App